Bill Information

House Bill 2527
2021-2022 Regular Session
An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for drug overdose medication.
Co-Sponsorship Memo
Prime Sponsor
Photo of Representative Representative Christopher Quinn
Representative Christopher Quinn
R House District 168
Co-Sponsors
Photo of Representative Rep. Nancy Guenst
Rep. Nancy Guenst
D House District 152
Photo of Representative Rep. F. Todd Polinchock
Rep. F. Todd Polinchock
R House District 144
Photo of Representative Rep. Carol Hill-Evans
Rep. Carol Hill-Evans
D House District 95
Photo of Representative Rep. Joe Ciresi
Rep. Joe Ciresi
D House District 146
Photo of Representative Rep. James Struzzi
Rep. James Struzzi
R House District 62
Photo of Representative Rep. Napoleon J. Nelson
Rep. Napoleon J. Nelson
D House District 154
Photo of Representative Rep. Christina Sappey
Rep. Christina Sappey
D House District 158
Photo of Representative Rep. David Rowe
Rep. David Rowe
R House District 85
Photo of Representative Rep. Mark Gillen
Rep. Mark Gillen
R House District 128
Photo of Representative Rep. David Zimmerman
Rep. David Zimmerman
R House District 99
Photo of Representative Rep. Joe Webster
Rep. Joe Webster
D House District 150
Photo of Representative Rep. Craig Williams
Rep. Craig Williams
R House District 160
Photo of Representative Rep. Dan Frankel
Rep. Dan Frankel
D House District 23
Bill Status & History
Last Action: Act No. 135 of 2022, Nov. 3, 2022
H
S
3004 Referred to Judiciary, April 20, 2022
3150 Reported as amended, May 24, 2022
First consideration, May 24, 2022
Laid on the table, May 24, 2022
Removed from table, June 14, 2022
Second consideration, June 15, 2022
Re-committed to Appropriations, June 15, 2022
Re-reported as committed, June 20, 2022
Third consideration and final passage, June 20, 2022 (200-0)
(Remarks see House Journal Page 666-667), Oct. 20, 2022
In the Senate
Referred to Judiciary, June 21, 2022
Reported as committed, Sept. 20, 2022
First consideration, Sept. 20, 2022
Second consideration, Oct. 18, 2022
Re-referred to Appropriations, Oct. 18, 2022
Re-reported as committed, Oct. 24, 2022
Third consideration and final passage, Oct. 24, 2022 (48-0)
(Remarks see Senate Journal Page 1084-1087), Oct. 24, 2022
Signed in House, Oct. 25, 2022
Signed in Senate, Oct. 26, 2022
Presented to the Governor, Oct. 26, 2022
Approved by the Governor, Nov. 3, 2022
Act No. 135 of 2022, Nov. 3, 2022
Printers Numbers
Apr 20, 2022
PN 3004
Amendments
Senate Amendments to Printers Number 3150
House Amendments to Printers Number 3004
Votes
Committee Meetings
(to consider House Bills No. 140, 397, 2373, 2525 and 2527)
(to consider House Bills No. 140, 397, 2373, 2525 and 2527)

(to consider Senate Bills No. 1317, 1321 and 1333; and House Bills No. 103, 185, 875, 1393, 1929 and 2527)
(to consider Senate Bills No. 1317, 1321 and 1333; and House Bills No. 103, 185, 875, 1393, 1929 and 2527)

Voting meeting on HB 1092, HB1093, HB1393, HB1419, HB1988, HB2032, HB2290, HB2344, HB2527, HB2580, HR 199 and any other business that may come before the committee.
Voting meeting on HB 1092, HB1093, HB1393, HB1419, HB1988, HB2032, HB2290, HB2344, HB2527, HB2580, HR 199 and any other business that may come before the committee.
Statute References

This bill amends the act of April 14, 1972 (P.L.0233, No.64), known as the Controlled Substance, Drug, Device And Cosmetic Act, The. Other bills amending the same statute are listed below.


House Bill 2527
2021-2022 Regular Session
Sponsors
QUINN, GUENST, POLINCHOCK, HILL-EVANS, CIRESI, STRUZZI, N. NELSON, SAPPEY, ROWE, GILLEN, ZIMMERMAN, WEBSTER, C. WILLIAMS, FRANKEL

Short Title
An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for drug overdose medication.

Memo Subject
Good Samaritan Legislation

Actions
3004 Referred to JUDICIARY, April 20, 2022
3150 Reported as amended, May 24, 2022
First consideration, May 24, 2022
Laid on the table, May 24, 2022
Removed from table, June 14, 2022
Second consideration, June 15, 2022
Re-committed to APPROPRIATIONS, June 15, 2022
Re-reported as committed, June 20, 2022
Third consideration and final passage, June 20, 2022 (200-0)
(Remarks see House Journal Page 666-667), Oct. 20, 2022
In the Senate
Referred to JUDICIARY, June 21, 2022
Reported as committed, Sept. 20, 2022
First consideration, Sept. 20, 2022
Second consideration, Oct. 18, 2022
Re-referred to APPROPRIATIONS, Oct. 18, 2022
Re-reported as committed, Oct. 24, 2022
Third consideration and final passage, Oct. 24, 2022 (48-0)
(Remarks see Senate Journal Page 1084-1087), Oct. 24, 2022
Signed in House, Oct. 25, 2022
Signed in Senate, Oct. 26, 2022
Presented to the Governor, Oct. 26, 2022
Approved by the Governor, Nov. 3, 2022
Act No. 135 of 2022, Nov. 3, 2022

Generated 03/23/2025 04:12 AM